Cory Renauer
Cory Renauer is a contributing Healthcare Analyst at The Motley Fool, covering publicly traded companies across pharmaceuticals, biotechnology, and medical devices. Prior to The Motley Fool, Cory was an educator in Thailand and a laboratory technician for the American Red Cross. He holds a B.S. in Biology from Oakland University. Fun fact: Cory has a collection of novelty socks featuring famous stock market symbols and iconic investor quotes.
Recent Articles by Cory Renauer

Dec 12, 2024
by Cory Renauer
Can SoFi Technologies Keep Soaring After a 131% Gain?

Nov 27, 2024
by Cory Renauer
Why Amgen's Weight Loss Result Is a Win for Eli Lilly
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.